Jefferies & Co Has Just Reaffirmed $62.00 Target Price Per Share on INC Research (NDAQ:INCR) stock, While They’ve Also Reiterated Their “Buy” Rating

June 19, 2017 - By Migdalia James

 Jefferies & Co Has Just Reaffirmed $62.00 Target Price Per Share on INC Research (NDAQ:INCR) stock, While They’ve Also Reiterated Their

Investors sentiment decreased to 1.2 in Q4 2016. Its down 0.84, from 2.04 in 2016Q3. It dived, as 21 investors sold INC Research Holdings Inc shares while 79 reduced holdings. 39 funds opened positions while 81 raised stakes. 51.39 million shares or 0.02% more from 51.38 million shares in 2016Q3 were reported.

Advisors Asset Mngmt has invested 0.04% of its portfolio in INC Research Holdings Inc (NASDAQ:INCR). One Trading Lp owns 3,669 shares or 0% of their US portfolio. Invesco Limited has 0.02% invested in INC Research Holdings Inc (NASDAQ:INCR) for 1.14 million shares. Deutsche Comml Bank Ag has invested 0.02% in INC Research Holdings Inc (NASDAQ:INCR). Point72 Asia (Hong Kong) has invested 0% in INC Research Holdings Inc (NASDAQ:INCR). State Street owns 0% invested in INC Research Holdings Inc (NASDAQ:INCR) for 824,747 shares. Gsa Capital Prns Limited Liability Partnership invested in 0.25% or 79,580 shares. Guggenheim Cap Ltd stated it has 0.01% in INC Research Holdings Inc (NASDAQ:INCR). Paloma Prtn Mngmt accumulated 21,416 shares. Hilltop Holdg owns 5,150 shares. Advisory Research accumulated 0.09% or 113,194 shares. Glenmede Na invested 0% of its portfolio in INC Research Holdings Inc (NASDAQ:INCR). Pdt Prtn Ltd Llc stated it has 112,300 shares. Geode Cap Mngmt Ltd Com reported 436,031 shares or 0.01% of all its holdings. Prelude Cap Ltd Liability has invested 0.01% in INC Research Holdings Inc (NASDAQ:INCR).

INC Research (NDAQ:INCR) Rating Reaffirmed

Jefferies & Co now has a $62.00 price target on shares of INC Research (NDAQ:INCR). The price target indicates a potential upside of 3.77 % from the close price of INC Research (NDAQ:INCR). This rating was shown in a report on Friday morning.

Investors sentiment decreased to 1.2 in Q4 2016. Its down 0.84, from 2.04 in 2016Q3. It dived, as 21 investors sold INC Research Holdings Inc shares while 79 reduced holdings. 39 funds opened positions while 81 raised stakes. 51.39 million shares or 0.02% more from 51.38 million shares in 2016Q3 were reported.

Advisors Asset Mngmt has invested 0.04% of its portfolio in INC Research Holdings Inc (NASDAQ:INCR). One Trading Lp owns 3,669 shares or 0% of their US portfolio. Invesco Limited has 0.02% invested in INC Research Holdings Inc (NASDAQ:INCR) for 1.14 million shares. Deutsche Comml Bank Ag has invested 0.02% in INC Research Holdings Inc (NASDAQ:INCR). Point72 Asia (Hong Kong) has invested 0% in INC Research Holdings Inc (NASDAQ:INCR). State Street owns 0% invested in INC Research Holdings Inc (NASDAQ:INCR) for 824,747 shares. Gsa Capital Prns Limited Liability Partnership invested in 0.25% or 79,580 shares. Guggenheim Cap Ltd stated it has 0.01% in INC Research Holdings Inc (NASDAQ:INCR). Paloma Prtn Mngmt accumulated 21,416 shares. Hilltop Holdg owns 5,150 shares. Advisory Research accumulated 0.09% or 113,194 shares. Glenmede Na invested 0% of its portfolio in INC Research Holdings Inc (NASDAQ:INCR). Pdt Prtn Ltd Llc stated it has 112,300 shares. Geode Cap Mngmt Ltd Com reported 436,031 shares or 0.01% of all its holdings. Prelude Cap Ltd Liability has invested 0.01% in INC Research Holdings Inc (NASDAQ:INCR).

INC Research Holdings Inc (NASDAQ:INCR) Ratings Coverage

Among 4 analysts covering INC Research (NDAQ:INCR), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. INC Research has $66 highest and $51 lowest target. $64’s average target is 5.87% above currents $60.45 stock price. INC Research had 5 analyst reports since April 24, 2017 according to SRatingsIntel. Jefferies maintained the shares of INCR in report on Monday, April 24 with “Buy” rating. Robert W. Baird upgraded INC Research Holdings Inc (NASDAQ:INCR) on Thursday, May 11 to “Outperform” rating. The firm earned “Overweight” rating on Monday, June 5 by KeyBanc Capital Markets. The stock of INC Research Holdings Inc (NASDAQ:INCR) has “Buy” rating given on Friday, June 16 by Jefferies. The firm has “Buy” rating given on Wednesday, May 31 by Suntrust Robinson.

About 3,031 shares traded. INC Research Holdings Inc (NDAQ:INCR) has risen 27.42% since June 19, 2016 and is uptrending. It has outperformed by 10.72% the S&P500.

INC Research Holdings, Inc. is a global contract research organization . The company has market cap of $3.28 billion. The Firm focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. It has a 28.77 P/E ratio. The Firm operates through two divisions: Clinical Development Services and Phase I Services.

More important recent INC Research Holdings Inc (NASDAQ:INCR) news were published by: Globenewswire.com which released: “INC Research to Present at Upcoming Jefferies Global Healthcare Conference” on May 31, 2017, also Nasdaq.com published article titled: “INC Research to Lead the Conversation on ICH E6 R2 Preparedness at DIA 2017 …”, Streetinsider.com published: “SunTrust Robinson Humphrey Upgrades INC Research Holdings (INCR) to Buy” on May 31, 2017. More interesting news about INC Research Holdings Inc (NASDAQ:INCR) was released by: Globenewswire.com and their article: “INC Research Announces 2017 “INCSights” Webinar Series to Advance Dialogue on …” with publication date: June 06, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.